Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -0.42 % |
3 Month Return | + 15.51 % |
1 Year Return | + 51.35 % |
Market Stats | |
Previous Close | ₹130.16 |
Open | ₹129.99 |
Volume | 9,397.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹207.23Cr |
P/E Ratio | 25.77 |
PEG Ratio | 7.36 |
Market Cap | ₹207.23 Cr |
P/B Ratio | 1.37 |
EPS | 4.71 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 10.19 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA | |
NA | ₹42.25 Cr | -16.52% | 0.50 | NA | NA |
Organisation | Bal Pharma Ltd |
Headquarters | Bangalore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Bal Pharma Ltd
Investors may be expecting limited growth rates for Bal Pharma Ltd, resulting in a low P/E ratio of 25.5x. While the company has seen rapid earnings growth in the past year and three-year period, its medium-term trajectory is expected to lag behind the broader market's forecasted expansion.
Bal Pharma Q4 FY24 Net Profit Jumps to Rs 5.53 Crore - 29 May, 2024
Bal Pharma's consolidated net profit for Q4 FY24 stood at Rs 5.53 crore, up from Rs 1.61 crore in Q4 FY23. The company's board has declared a dividend of Rs 1.20 per equity share. Bal Pharma stock locked in an upper circuit of 20%.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 48.64% to 49.01% in Sep 2024 quarter
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 32.4%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.13% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 102.0%
Promoter Holding Down
Promoters have decreased holdings from 51.23% to 50.86% in Sep 2024 quarter
Price Dip
In the last 7 days, BALPHARMA stock has moved down by -3.6%
Revenue Fall
Revenue is down for the last 2 quarters, 97.08 Cr → 75.18 Cr (in ₹), with an average decrease of 22.6% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 5.47 Cr → 0.26 Cr (in ₹), with an average decrease of 95.3% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 50.86% | ||
Foreign Institutions | 0.13% | 0.54 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 49.01% | 0.77 | |
Others | 0% | 0.00 |
Bal Pharma Ltd in the last 5 years
Lowest (-535.88x)
June 15, 2018
Today (25.77x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (203.65x)
September 12, 2018
Bal Pharma Ltd’s net profit jumped 225% since last year same period to ₹0.26Cr in the Q1 2024-2025. On a quarterly growth basis, Bal Pharma Ltd has generated -95.25% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Bal Pharma Ltd has declared dividend of ₹1.20 - translating a dividend yield of 1.70%.
Read More about DividendsBearish
Neutral
Bullish
Bal Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Bal Pharma Ltd (BALPHARMA) share price today is ₹129.05
Bal Pharma Ltd is listed on NSE
Bal Pharma Ltd is listed on BSE
PE Ratio of Bal Pharma Ltd is 25.77
PE ratio = Bal Pharma Ltd Market price per share / Bal Pharma Ltd Earnings per share
Today’s traded volume of Bal Pharma Ltd(BALPHARMA) is 9,397.00.
Today’s market capitalisation of Bal Pharma Ltd(BALPHARMA) is ₹207.23Cr.
Bal Pharma Ltd(BALPHARMA | Price |
---|---|
52 Week High | ₹157.98 |
52 Week Low | ₹81.2 |
Bal Pharma Ltd(BALPHARMA) share price is ₹129.05. It is down -18.31% from its 52 Week High price of ₹157.98
Bal Pharma Ltd(BALPHARMA) share price is ₹129.05. It is up 58.93% from its 52 Week Low price of ₹81.2
Bal Pharma Ltd(BALPHARMA | Returns |
---|---|
1 Day Returns | -1.11% |
1 Month Returns | -0.42% |
3 Month Returns | 15.51% |
1 Year Returns | 51.35% |